Conquering epilepsies & brain disorders with courageous science
Science-driven and patient-focused, our mission is to develop medicines that transform the lives of patients with epilepsies and seizure-related disorders.
Our deep understanding of human genetics and cellular function enables us to translate discoveries into meaningful therapies for epilepsies and seizure-related disorders.
At Ovid, we seek to understand what matters most to individuals with rare diseases and their families. We are committed to address the challenges they face every day.
- Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2022 Financial Results
- Ovid Therapeutics to Present at the 2nd Annual Needham Virtual Neuroscience Forum
- Studies Published in Cell Reports Medicine Validate the Potential of Direct KCC2 Activation in Resistant Seizures
- Ovid Therapeutics to Present at the 43rd Annual Cowen Healthcare Conference
Each team member understands the difference between a drug and a medicine—one is a product, the other changes lives—and that's what brings us together as Ovidians.